2020-07-17| PartnerAsia-Pacific


by GeneOnline
Share To

ITALY will once more be part of this trade show, at BIO ASIA TAIWAN 2020 – ONLINE.

The Italian pavilion, organized by ITA – Italian Trade Agency – and Italian Ministry of Foreign Affairs and International Cooperation will feature a delegation of 7 leading Italian biotech companies that encompass new biopharma, 3D medical printing, biotech services and bioindustry park.

3DIFIC S.r.l., a medical 3d printing company. They focus on a deep interaction with surgeons to understand precisely their necessities. They support doctors, scientists, and students to provide doctors with any patient-specific device they want.

The BIOINDUSTRY PARK SILVANO FUMERO S.p.a. which is located in the Piedmont region. The cluster of Piedmont gathers about 100 companies, research centers, R&D organizations and academic institutions in the healthcare sector. It has acted as a system integrator for the development of Life Sciences since its creation in 1998. Connect with them to find out about those companies and the Bioindustry Park.

In recent years IBSA FARMACEUTICI S.r.l. Italia has increased, becoming a significant economic and scientific company in the Italian pharmaceutical sector. Research and Development activities use advanced technology to study innovative methods for administering drugs. Today IBSA Farmaceutici Italia guarantees a vast number of products, ranging from people’s wellbeing to care and prevention, and covers 12 main therapeutic areas: Cardiometabolic, Dermatology, Dermo-aesthetic, Endocrinology, Human Reproduction, Osteoarticular, Pain and Inflammation, Respiratory, Urology, Ophthalmics, Otorhinolaryngology and Consumer Health.

For biopharmaceutical and med-tech companies that want to adopt global business development strategy, PHARMA & BIOTECH ADVISORS S.r.l. from Italy provides clients to solve their problems in strategy, operations, organization and change. Especially in advising firms in-licensing and alliances, portfolio management and emerging therapeutic/technological areas.

On the cell biotechnology field, REMEMBRANE S.r.l., an ISO 9001:2015 certified European SME. Its technology includes envisaging the cell membrane network and its lipid composition as a cornerstone of cell physiology. Remembrane designs, develops, and manufactures customised GMP-grade membrane-targeting Lipid Mixtures commercialized under the brand name Refeed.

SYNAPTICOM S.r.l.‘s patented active ingredients are supported by preclinical and clinical research and combined with innovative formulas, which are now widely used in therapy. The research results generated a “Drug-non-Drug” product platform registered as cosmetics and supplements, adding higher scientific value, thereby opening up a whole new market. Their most advanced pharmaceutical technology enables them to improve the bioavailability and effectiveness of the preparation.

VERA SALUS RICERCA S.r.l.’s an innovative biopharma company whose core capability is to discover best-in-class drug candidates that originated from natural compounds. Research is led by Prof. Giovanni Pitari from T. Jefferson University of Philadelphia, in collaboration with the Italian National Council for Research (CNR).

It is exciting to find out more about them in company presentations or virtual exhibitions during BIO Asia-Taiwan. You may also connect with their CEOs and executives during the one-on-one partnering event from July 22 to 26.

* Those Italian companies will be on July 24 in the company presentation section according to the schedule below!

24th, July, 2020

19:30 – 19:40 Vera Salus Ricerca S.r.l.
19:40 – 19:50 3DIFIC S.r.l.
19:50 – 20:00 Bioindustry Park Silvano Fumero S.p.a.
20:00 – 20:10 IBSA Farmaceutici S.r.l.
20:10 – 20:20 Pharma & Biotech Advisors S.r.l.
20:20 – 20:30 Remembrane S.r.l.
20:30 – 20:40 Synapticom S.r.l.


Make sure to sign up and check out those companies at the company presentation!


© All rights reserved. Collaborate with us:
Related Post
3D Printed Brain Model Could Aid in Neurosurgery
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
BIO Asia-Taiwan 2022: Looking for the Exit; Startup Considerations and Strategies
BIO 2023 Coming to Boston, with Over 60 Taiwanese Organizations to Share their Achievements
2023 ASGCT Annual Meeting: Showcase of Exciting New Research, with a Focus on Clinical Applications
Pfizer’s RSV Vaccine Gets FDA Approval for Use in Older Adults
Brazil’s Evolving ESG Landscape from the Amazon to Atlantic Forest
Should People Looking to Lose Weight Skip Sugar Substitutes?
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
Scroll to Top